Cargando…

Lineage Commitment in the Thymus: Only the Most Differentiated (TCR(hi)bcl-2(hi)) Subset of CD4(+)CD8(+)Thymocytes Has Selectively Terminated CD4 or CD8 Synthesis

Lineage commitment is a developmental process by which individual CD4(+)CD8(+) (double positive, DP) thymocytes make a decision to differentiate into either CD4(+) or CD8(+) T cells. However, the molecular event(s) that defines lineage commitment is controversial. We have previously proposed that li...

Descripción completa

Detalles Bibliográficos
Autores principales: Punt, Jennifer A., Suzuki, Harumi, Granger, Larry G., Sharrow, Susan O., Singer, Alfred
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196385/
https://www.ncbi.nlm.nih.gov/pubmed/8976166
Descripción
Sumario:Lineage commitment is a developmental process by which individual CD4(+)CD8(+) (double positive, DP) thymocytes make a decision to differentiate into either CD4(+) or CD8(+) T cells. However, the molecular event(s) that defines lineage commitment is controversial. We have previously proposed that lineage commitment in DP thymocytes can be molecularly defined as the selective termination of CD4 or CD8 coreceptor synthesis. The present study supports such a molecular definition by showing that termination of either CD4 or CD8 synthesis is a highly regulated event that is only evident within the most differentiated DP subset (CD5(hi)CD69(hi)TCR(hi)bcl-2(hi)). In fact, essentially all cells within this DP subset actively synthesize only one coreceptor molecule. In addition, the present results identify three distinct subpopulations of DP thymocytes that define the developmental progression of the lineage commitment process and demonstrate that lineage commitment is coincident with upregulation of TCR and bcl-2. Thus, this study supports a molecular definition of lineage commitment and uniquely identifies TCR(hi)bcl-2(hi) DP thymocytes as cells that are already committed to either the CD4 or CD8 T cell lineage.